Total Payments
$80,051
2024 Payments
$40,085
Companies
16
Transactions
210
Medicare Patients
443
Medicare Billing
$78,367
Payment Breakdown by Category
Other$44,542 (55.6%)
Travel$22,565 (28.2%)
Food & Beverage$6,505 (8.1%)
Consulting$6,430 (8.0%)
Education$9.09 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $43,842 | 41 | 54.8% |
| Travel and Lodging | $22,565 | 55 | 28.2% |
| Food and Beverage | $6,505 | 106 | 8.1% |
| Consulting Fee | $6,430 | 6 | 8.0% |
| Honoraria | $700.00 | 1 | 0.9% |
| Education | $9.09 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $40,328 | 79 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $23,602 | 53 | $0 (2024) |
| Celgene Corporation | $13,689 | 56 | $0 (2024) |
| PFIZER INC. | $735.21 | 2 | $0 (2023) |
| CTI BioPharma Corp. | $700.00 | 1 | $0 (2022) |
| SERVIER PHARMACEUTICALS LLC | $353.80 | 2 | $0 (2024) |
| Seagen Inc. | $132.14 | 1 | $0 (2021) |
| Astellas Pharma US Inc | $115.82 | 4 | $0 (2024) |
| Genentech, Inc. | $94.19 | 1 | $0 (2022) |
| Adaptive Biotechnologies Corporation | $78.92 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40,085 | 88 | GlaxoSmithKline, LLC. ($31,087) |
| 2023 | $19,483 | 58 | GlaxoSmithKline, LLC. ($9,241) |
| 2022 | $13,880 | 43 | E.R. Squibb & Sons, L.L.C. ($11,136) |
| 2021 | $6,603 | 21 | Celgene Corporation ($6,423) |
All Payment Transactions
210 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $690.00 | General |
| Category: Hematology | ||||||
| 12/18/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $828.00 | General |
| Category: Hematology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Travel and Lodging | Cash or cash equivalent | $583.46 | General |
| Category: Hematology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Hematology | ||||||
| 11/22/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Travel and Lodging | Cash or cash equivalent | $27.05 | General |
| Category: Hematology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Travel and Lodging | Cash or cash equivalent | $724.69 | General |
| Category: Hematology | ||||||
| 11/20/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: Hematology | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $26.75 | General |
| Category: ONCOLOGY | ||||||
| 11/18/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $2.55 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,560.00 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | Cash or cash equivalent | $28.06 | General |
| Category: ONCOLOGY | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | Cash or cash equivalent | $25.00 | General |
| Category: ONCOLOGY | ||||||
| 10/29/2024 | Astellas Pharma US Inc | Cresemba (Drug) | Food and Beverage | In-kind items and services | $33.38 | General |
| Category: Infectious Diseases | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | REBLOZYL (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $276.00 | General |
| Category: Hematology | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | In-kind items and services | $830.49 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | In-kind items and services | $282.62 | General |
| Category: ONCOLOGY | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $122.06 | General |
| Category: ONCOLOGY | ||||||
| 09/30/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,560.00 | General |
| Category: ONCOLOGY | ||||||
| 09/27/2024 | SERVIER PHARMACEUTICALS LLC | — | Food and Beverage | In-kind items and services | $23.80 | General |
| 09/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | Cash or cash equivalent | $14.74 | General |
| Category: ONCOLOGY | ||||||
| 09/25/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | Cash or cash equivalent | $11.89 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,560.00 | General |
| Category: ONCOLOGY | ||||||
| 09/05/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | In-kind items and services | $124.81 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Food and Beverage | Cash or cash equivalent | $24.28 | General |
| Category: ONCOLOGY | ||||||
| 08/23/2024 | GlaxoSmithKline, LLC. | OJJAARA (Drug) | Travel and Lodging | Cash or cash equivalent | $10.05 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 135 | 328 | $130,758 | $29,428 |
| 2022 | 2 | 100 | 213 | $85,581 | $19,454 |
| 2021 | 2 | 103 | 209 | $80,967 | $18,290 |
| 2020 | 3 | 105 | 162 | $57,892 | $11,195 |
Total Patients
443
Total Services
912
Medicare Billing
$78,367
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 70 | 230 | $98,670 | $23,063 | 23.4% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2023 | 53 | 79 | $23,937 | $4,367 | 18.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 19 | $8,151 | $1,998 | 24.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 57 | 167 | $71,643 | $17,018 | 23.8% |
| 38222 | Biopsy and aspiration of bone marrow sample for diagnosis | Facility | 2022 | 43 | 46 | $13,938 | $2,437 | 17.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 50 | 140 | $60,060 | $14,342 | 23.9% |
| 38222 | Diagnostic aspirations and biopsies of bone marrow | Facility | 2021 | 53 | 69 | $20,907 | $3,948 | 18.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 39 | 71 | $30,459 | $5,743 | 18.9% |
| 38222 | Bone marrow biopsy and aspiration | Facility | 2020 | 43 | 56 | $16,968 | $3,357 | 19.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 23 | 35 | $10,465 | $2,095 | 20.0% |
About Felipe Novoa, ARNP
Felipe Novoa, ARNP is a Family healthcare provider based in Miami, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1770905283.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Felipe Novoa, ARNP has received a total of $80,051 in payments from pharmaceutical and medical device companies, with $40,085 received in 2024. These payments were reported across 210 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($43,842).
As a Medicare-enrolled provider, Novoa has provided services to 443 Medicare beneficiaries, totaling 912 services with total Medicare billing of $78,367. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Miami, FL
- Active Since 01/17/2014
- Last Updated 01/17/2014
- Taxonomy Code 363LF0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1770905283
Products in Payments
- OJJAARA (Drug) $40,304
- REBLOZYL (Biological) $22,578
- ONUREG (Drug) $3,789
- BESPONSA (Biological) $720.00
- Vonjo (Drug) $700.00
- Tibsovo (Drug) $330.00
- ADCETRIS (Biological) $132.14
- Cresemba (Drug) $95.52
- clonoSEQ (Device) $78.92
- DARZALEX (Biological) $53.66
- ELZONRIS (Drug) $43.11
- SCEMBLIX (Drug) $42.50
- Empaveli (Drug) $26.50
- TASIGNA (Drug) $26.33
- SHINGRIX (Biological) $23.96
- Xospata (Drug) $20.30
- XARELTO (Drug) $15.89
- BOSULIF (Drug) $15.21
- Kyprolis (Drug) $13.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Miami
Yamila Melendez, Arnp, ARNP
Family — Payments: $142,106
Family $142,106
Suzan Rosen, Aprn, APRN
Family — Payments: $107,821
Family $107,821
Dr. Pamela Dudkiewicz, Arnp, ARNP
Family — Payments: $66,729
Family $66,729
Stacy Feemster, Np, NP
Family — Payments: $51,398
Family $51,398
Patrick Szaraz, Fnp, FNP
Family — Payments: $35,665
Family $35,665
Estrella Moreno Rodriguez, Aprn, APRN
Family — Payments: $29,793
Family $29,793